|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Real estate assets, net | ||||||||||||||||||||
| Investments in unconsolidated real estate entities | ||||||||||||||||||||
| Investments in real estate-related loans, net | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities, Equity, and Noncontrolling Interests | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Mortgage notes and revolving credit facility, net | ||||||||||||||||||||
| Construction loan, net | ||||||||||||||||||||
| Land loans, net | ||||||||||||||||||||
| Preferred stock, net | ||||||||||||||||||||
| Preferred Interest Liability | ||||||||||||||||||||
| Unsecured promissory notes, net | ||||||||||||||||||||
| Performance participation allocation due to affiliate | ||||||||||||||||||||
| Related party payables | ||||||||||||||||||||
| Accounts payable, accrued expenses and other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Equity and noncontrolling interests | ||||||||||||||||||||
| Stockholders' equity | ||||||||||||||||||||
| Series A Convertible Preferred Stock, $0.01 par value, 15,000,000 shares authorized at $10.00 per share; 10,595,987 and 5,825,457 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively. | ||||||||||||||||||||
| Common stock | ||||||||||||||||||||
| T | ||||||||||||||||||||
| Class D | ||||||||||||||||||||
| I | ||||||||||||||||||||
| A | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated distributions | ||||||||||||||||||||
| Series A Convertible Preferred Stock | ||||||||||||||||||||
| Common Stock | ||||||||||||||||||||
| Total accumulated distributions | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Noncontrolling interests | ||||||||||||||||||||
| Limited partners | ||||||||||||||||||||
| Partially owned entities | ||||||||||||||||||||
| Total noncontrolling interests | ||||||||||||||||||||
| Total equity and noncontrolling interests | ||||||||||||||||||||
| Total liabilities, equity and noncontrolling interests | ||||||||||||||||||||
Loading...
